Kybella™

According to a survey by the American Society for Dermatologic Surgery (ASDS), more than two-thirds of consumers are bothered by submental fullness — nearly as many as those bothered by lines and wrinkles around the eyes.

Kybella is only used for improvement in the appearance of moderate to severe convexity or fullness associated with submental fat in adults. The safe and effective use of Kybella for the treatment of subcutaneous fat outside the submental region has not been established and is not recommended.

It has been the focus of a global clinical development program involving over 20 clinical studies with more than 2,600 patients worldwide, of which over 1,600 have been treated with Kybella. In the pooled, pivotal Phase III clinical trials, 68.2 percent of patients responded to Kybella, compared to 20.5 percent of patients who responded to placebo, based on validated physician and patient measurements.

Treatment with Kybella is customized by Dr. Wise to the patient’s aesthetic goals for an improved chin profile. It’s administered by injections into the fat under the chin. In clinical trials, the average dose is approximately 4 to 6 mL delivered in 0.2 mL injections spaced approximately 1 cm apart per treatment session.

The number of injections and the number of treatments should be tailored to the individual patient’s submental fat distribution and treatment goals. Many patients experience visible results in two to four treatment sessions spaced at least one month apart. Up to six treatments may be administered — 59% of patients receive all six treatments.